{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"35"}],"units":"Participants"}],"description":"Number of patients who had objective responses after radiology review","groups":[{"description":"Patients receive oral sunitinib malate once daily on days 1-28. Treatment repeats every 6 weeks in the absence of disease progression or unacceptable toxicity.","id":"OG000","title":"Treatment (Sunitinib Malate)"}],"paramType":"NUMBER","populationDescription":"1 cancelled patient and 4 ineligible patients were excluded from analysis.","reportingStatus":"POSTED","timeFrame":"Up to 3 years","title":"Objective Response (Partial and Complete) Per RECIST","type":"PRIMARY","unitOfMeasure":"participants"}